Laumon Bernard, Gadegbeku Blandine, Martin Jean-Louis, Biecheler Marie-Berthe
French National Institute for Transport and Safety Research (INRETS), Epidemiological Research and Surveillance Unit in Transport, Occupation and Environment (UMRESTTE), 25 avenue François Mitterrand, F-69675 Bron Cedex.
BMJ. 2005 Dec 10;331(7529):1371. doi: 10.1136/bmj.38648.617986.1F. Epub 2005 Dec 1.
To evaluate the relative risk of being responsible for a fatal crash while driving under the influence of cannabis, the prevalence of such drivers within the driving population, and the corresponding share of fatal crashes.
Population based case-control study.
10 748 drivers, with known drug and alcohol concentrations, who were involved in fatal crashes in France from October 2001 to September 2003.
The cases were the 6766 drivers considered at fault in their crash; the controls were 3006 drivers selected from the 3982 other drivers. Positive detection of cannabis was defined as a blood concentration of Delta9tetrahydrocannabinol of over 1 ng/ml. The prevalence of positive drivers in the driving population was estimated by standardising controls on drivers not at fault who were involved in crashes resulting in slight injuries.
681 drivers were positive for cannabis (cases 8.8%, controls 2.8%), including 285 with an illegal blood alcohol concentration (> or = 0.5 g/l). Positive cannabis detection was associated with increased risk of responsibility (odds ratio 3.32, 95% confidence interval 2.63 to 4.18). A significant dose effect was identified; the odds ratio increased from 2.18 (1.22 to 3.89) if 0 < Delta9tetrahydrocannabinol < 1 ng/ml to 4.72 (3.04 to 7.33) if Delta9tetrahydrocannabinol > or = 5 ng/ml. The effect of cannabis remains significant after adjustment for different cofactors, including alcohol, with which no statistical interaction was observed. The prevalence of cannabis (2.9%) estimated for the driving population is similar to that for alcohol (2.7%). At least 2.5% (1.5% to 3.5%) of fatal crashes were estimated as being attributable to cannabis, compared with 28.6% for alcohol (26.8% to 30.5%).
Driving under the influence of cannabis increases the risk of involvement in a crash. However, in France its share in fatal crashes is significantly lower than that associated with positive blood alcohol concentration.
评估在大麻影响下驾驶导致致命撞车事故的相对风险、此类驾驶员在驾驶人群中的患病率以及在致命撞车事故中所占的相应比例。
基于人群的病例对照研究。
2001年10月至2003年9月期间在法国发生致命撞车事故且已知药物和酒精浓度的10748名驾驶员。
病例为6766名在撞车事故中被认定有过错的驾驶员;对照为从3982名其他驾驶员中选出的3006名驾驶员。大麻阳性检测定义为血液中Δ9-四氢大麻酚浓度超过1纳克/毫升。通过对未造成轻微伤害的撞车事故中无过错驾驶员的对照进行标准化,估计驾驶人群中大麻阳性驾驶员的患病率。
681名驾驶员大麻检测呈阳性(病例组8.8%,对照组2.8%),其中285名血液酒精浓度非法(≥0.5克/升)。大麻阳性检测与责任风险增加相关(比值比3.32,95%置信区间2.63至4.18)。确定了显著的剂量效应;如果0<Δ9-四氢大麻酚<1纳克/毫升,比值比从2.18(1.22至3.89)增加到如果Δ9-四氢大麻酚≥5纳克/毫升时的4.72(3.04至7.33)。在对包括酒精在内的不同协变量进行调整后,大麻的影响仍然显著,未观察到统计学上的相互作用。估计驾驶人群中大麻的患病率(2.9%)与酒精的患病率(2.7%)相似。估计至少2.5%(1.5%至3.5%)的致命撞车事故可归因于大麻,而酒精为28.6%(26.8%至30.5%)。
在大麻影响下驾驶会增加撞车事故的风险。然而,在法国,其在致命撞车事故中所占比例显著低于血液酒精浓度阳性相关的比例。